Antithrombin (AT), a plasma serine protease inhibitor (serpin), inactivates factor Xa and thrombin by a branched pathway, suicide substrate inhibition mechanism in which an initial reversible Michaelis complex is converted into a tetrahedral or an acyl-enzyme intermediate similar to the normal reaction of these enzymes with their true substrates. In contrast to true substrates, however, a conformational change in the reactive site loop of the serpin leads to insertion of the loop into the A-beta-sheet of the molecule. This results in distortion of the catalytic machinery so that the intermediate is deacylated very slowly and, therefore, is trapped as a kinetically stable, irreversible complex. Unlike AT, binding of the non-serpin inhibitor, tissue factor pathway inhibitor, to factor Xa traps the protease as a reversible, high affinity Michaelis complex. AT is relatively inactive unless it binds to the heparin-like glycosaminoglycans, which are either present in the microvasculature or therapeutically administered for prophylaxis and treatment of venous thrombosis. The low inhibitory activity of AT is due to partial preinsertion of the reactive site loop of AT into the A-beta-sheet of the molecule. Heparin binding to AT induces a conformational change in the reactive site loop of the serpin that causes the expulsion of this inserted region thereby conferring a canonical conformation for the loop that is complimentary to the active site pocket of protease. We have prepared several serpin and protease mutants to investigate the following five Aims: 1) determine the contribution of the catalytic Ser195 of the proteases in binding to the serpin and non-serpin inhibitors; 2) determine whether the AT-protease complexes are trapped as tetrahedral or acyl-enzyme intermediates; 3) determine how heparin might catalyze the AT inactivation of factor Xa in the prothrombinase complex; 4) determine whether there is a heparin binding """"""""exosite"""""""" on factor Xa, analogous to that in thrombin; and 5) determine the structural basis for the partial loon preinsertion and the resulting non-canonical conformation of the reactive site loop of the serpin.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL062565-03
Application #
6184853
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1999-04-01
Project End
2003-03-31
Budget Start
2000-04-01
Budget End
2001-03-31
Support Year
3
Fiscal Year
2000
Total Cost
$215,322
Indirect Cost
Name
Saint Louis University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63103
Dinarvand, P; Yang, L; Villoutreix, B O et al. (2018) Expression and functional characterization of two natural heparin-binding site variants of antithrombin. J Thromb Haemost 16:330-341
Biswas, Indranil; Panicker, Sumith R; Cai, Xiaofeng et al. (2018) Inorganic Polyphosphate Amplifies High Mobility Group Box 1-Mediated Von Willebrand Factor Release and Platelet String Formation on Endothelial Cells. Arterioscler Thromb Vasc Biol 38:1868-1877
Yang, Likui; Rezaie, Alireza R (2017) Characterization of Protein Z-Dependent Protease Inhibitor/Antithrombin Chimeras Provides Insight into the Serpin Specificity of Coagulation Proteases. ACS Omega 2:3276-3283
Ding, Qiulan; Yang, Likui; Zhao, Xiaoqing et al. (2017) Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation. Thromb Haemost 117:479-490
Lee, Eun-Ju; Dykas, Daniel J; Leavitt, Andrew D et al. (2017) Whole-exome sequencing in evaluation of patients with venous thromboembolism. Blood Adv 1:1224-1237
Chen, Changming; Yang, Likui; Villoutreix, Bruno O et al. (2017) Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function. Thromb Haemost 117:1358-1369
Hassanian, S M; Ardeshirylajimi, A; Dinarvand, P et al. (2016) Inorganic polyphosphate promotes cyclin D1 synthesis through activation of mTOR/Wnt/?-catenin signaling in endothelial cells. J Thromb Haemost 14:2261-2273
Roy, Ram Vinod; Ardeshirylajimi, Abdolreza; Dinarvand, Peyman et al. (2016) Occupancy of human EPCR by protein C induces ?-arrestin-2 biased PAR1 signaling by both APC and thrombin. Blood :
Hassanian, S M; Dinarvand, P; Smith, S A et al. (2015) Inorganic polyphosphate elicits pro-inflammatory responses through activation of the mammalian target of rapamycin complexes 1 and 2 in vascular endothelial cells. J Thromb Haemost 13:860-71
Dinarvand, Peyman; Hassanian, Seyed Mahdi; Weiler, Hartmut et al. (2015) Intraperitoneal administration of activated protein C prevents postsurgical adhesion band formation. Blood 125:1339-48

Showing the most recent 10 out of 100 publications